US › Healthcare

Pulmatrix Inc (PULM)

US · Healthcare · Biotechnology

$1.66-4.60%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-1.2M
Profit YoY
+35.2%
EPS
$-0.32

Key statistics

Market cap
$6.4M
Forward P/E
0.0
P/B
2.41
Book value
$0.72
EPS (TTM)
$-1.23
52-week high
$5.58
52-week low
$1.16
50-day MA
$1.55
200-day MA
$2.50
Beta
1.90

Analyst view

Analysts rate Pulmatrix Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Shareholding

Insiders
0.77%
Institutions
9.05%

Largest institutional holders

FundStake
Renaissance Technologies Corp2.99%
BlackRock Inc1.50%
Vanguard Group Inc1.29%
Geode Capital Management, LLC1.22%
Vanguard Capital Management, LLC0.92%
SBI Securities Co Ltd0.82%
Vanguard Fiduciary Trust Co0.40%
Jane Street Group LLC0.40%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Pulmatrix Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.